Materialise (ADR) (MTLS)
Connects additive-manufacturing software, medical applications, and industrial production services.
Something off on this page? Send us feedback.
Sells software, patient-specific medical offerings, and industrial manufacturing services for additive manufacturing. Its three segments connect digital design and medical imaging to production.
Links digital design and medical imaging to additive-manufacturing production through Materialise Medical, Materialise Software, and Materialise Manufacturing. Medical includes patient-specific healthcare applications, while Software supplies proprietary tools and Manufacturing provides industrial production services.
Founded as a 3D-printing service business, it developed Mimics to turn CT-scan data into patient-specific anatomical models. Software is transitioning toward cloud and subscription-based delivery while continuing research and development work.
Based in Leuven, Belgium, the group retains a Nasdaq ADS listing and also completed a Euronext listing. Its operating structure centers on the three reportable segments.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Feb 20, 2026 | Cantor Fitzgerald | Target | Target: — | Target: $10 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $153.0M · Total debt $68.1M · Total assets $477.8M · Shareholders' equity $293.3M
- Revenue
- $81.5M
- Operating income
- $2.3M
- Net income
- $3.9M
Reported in EUR, converted at the latest exchange rate
No dividends on record.
| Institutions | 13.81% | 8.09M ADS | |
|---|---|---|---|
| 63 holders · as of Jun 30, 2026 | |||
| Other | 86.19% | 50.47M ADS | |
| remainder | |||
58.56M ADS as of Sep 12, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
The share count is from the company's Dec 2023 annual report; nothing newer is on file here.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Nikko Asset Management Americas, Inc.Institution | 4.51% | 2.64M | filed Feb 14, 2022 |
Disciplined Growth Investors Inc /MNInstitution | 3.40% | 1.99M ADS | as of Jun 30, 2026 |
Rock Point Advisors, LLCInstitution | 1.69% | 990,871 ADS | as of Jun 30, 2026 |
Archon Capital Management LLCInstitution | 1.31% | 766,622 ADS | as of Jun 30, 2026 |
King Luther Capital Management CorpInstitution | 1.07% | 628,750 ADS | as of Jun 30, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
- 3D Systems
Patient-matched surgical planning and 3D-printed medical solutions
- Stratasys
Medical anatomical models and additive-manufacturing systems
- Proto Labs
On-demand 3D printing for prototype and production parts
- Zimmer Biomet
Patient-matched implants designed from CT and 3D reconstruction
- Stryker
Patient-specific surgical planning and 3D-printed CMF implants
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Materialise (ADR) | $7.85 | +0.84% | $455.6M | — | 57.1 | — | +6.7% |
| 3D Systems | $3.62 | +3.88% | $568.4M | — | — | 1.5 | −0.3% |
| Stratasys | $8.14 | +2.91% | $686.7M | — | 59.2 | 1.3 | −0.4% |
| Proto Labs | $89.24 | +1.77% | $2.09B | 70.1 | 39.0 | 3.7 | +10.6% |
| Zimmer Biomet | $93.78 | −0.57% | $18.25B | 22.9 | 10.7 | 2.1 | +4.8% |
| Stryker | $275.61 | +0.52% | $105.11B | 28.4 | 17.2 | 4.1 | +9.4% |
| Median | 28.4 | 28.1 | 2.1 | +4.8% |